Neuropsychological prediction of dementia in Parkinson's disease.

Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord (2012) 5.12

MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord (2011) 2.27

Volumetric correlates of cognitive functioning in nondemented patients with Parkinson's disease. Mov Disord (2013) 1.45

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain (2011) 1.22

Psychotic symptoms in Parkinson's disease. From description to etiology. J Neurol (2005) 1.14

Early Parkinson's disease: longitudinal changes in brain activity during sequence learning. Neurobiol Dis (2009) 1.00

The spectrum of cognitive impairment in Lewy body diseases. Mov Disord (2014) 0.96

The fate of the 0.5s: predictors of 2-year outcome in mild cognitive impairment. J Int Neuropsychol Soc (2010) 0.95

Effect of levodopa on cognitive function in Parkinson's disease with and without dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry (2006) 0.95

Rule-based category learning in patients with Parkinson's disease. Neuropsychologia (2009) 0.95

Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease. Brain (2009) 0.92

Parkinson's disease disrupts both automatic and controlled processing of action verbs. Brain Lang (2012) 0.91

Executive dysfunction in Parkinson's disease and timing deficits. Front Integr Neurosci (2013) 0.89

Quality of life in Parkinson's disease. J Med Life (2012) 0.88

Cognitive and SPECT characteristics predict progression of Parkinson's disease in newly diagnosed patients. J Neurol (2004) 0.86

Beyond tremor and rigidity: non-motor features of Parkinson's disease. J Neural Transm (Vienna) (2009) 0.85

Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry (1999) 0.83

Exercise improves cognition in Parkinson's disease: The PRET-PD randomized, clinical trial. Mov Disord (2015) 0.83

Mild cognitive impairment in Parkinson's disease: the challenge and the promise. Neuropsychiatr Dis Treat (2005) 0.82

Neural substrates of cognitive subtypes in Parkinson's disease: a 3-year longitudinal study. PLoS One (2014) 0.80

Cognition, language, and clinical pathological features of non-Alzheimer's dementias: an overview. J Commun Disord (2010) 0.79

The neurobiology and neural circuitry of cognitive changes in Parkinson's disease revealed by functional neuroimaging. Mov Disord (2012) 0.78

Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's disease. Front Neurol (2015) 0.78

Mild cognitive impairment exists in Parkinson's disease. J Neural Transm (Vienna) (2011) 0.77

The epidemiology and clinical manifestations of dysexecutive syndrome in Parkinson's disease. Front Neurol (2012) 0.76

Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1998) 0.75

DEVELOPMENT OF CLINICAL DEMENTIA RATING SCALE CUTOFF SCORES FOR PATIENTS WITH PARKINSON'S DISEASE. Mov Disord Clin Pract (2015) 0.75

Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal. J Neural Transm (Vienna) (2017) 0.75

"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res (1975) 301.74

Parkinsonism: onset, progression and mortality. Neurology (1967) 36.06

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry (1992) 33.67

The mini-mental state examination: a comprehensive review. J Am Geriatr Soc (1992) 15.32

A rating instrument for anxiety disorders. Psychosomatics (1974) 7.53

A modified card sorting test sensitive to frontal lobe defects. Cortex (1976) 6.86

Depression and Parkinson's disease: a review. Am J Psychiatry (1992) 4.36

Visuospatial judgment. A clinical test. Arch Neurol (1978) 3.37

Neuropsychological detection and characterization of preclinical Alzheimer's disease. Neurology (1995) 3.37

A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol (1993) 3.00

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology (1994) 2.84

Cognitive deficits in the early stages of Parkinson's disease. Brain (1983) 2.65

'Subcortical dementia': the neuropsychological evidence. Neuroscience (1988) 2.08

The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol (1996) 1.94

How common is dementia in Parkinson's disease? Lancet (1984) 1.93

Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: evidence for a specific attentional dysfunction. Neuropsychologia (1989) 1.87

Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology (1995) 1.84

Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci (1990) 1.76

Dementia in Parkinson Disease. Ann Neurol (1979) 1.76

Antecedent clinical features associated with dementia in Parkinson's disease. Neurology (1993) 1.74

The effect of Parkinson's disease on the ability to maintain a mental set. J Neurol Neurosurg Psychiatry (1985) 1.59

A population-based investigation of Parkinson's disease with and without dementia. Relationship to age and gender. Arch Neurol (1992) 1.59

Dementia in Parkinson's disease. Acta Neurol Scand (1976) 1.54

The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol (1995) 1.51

The reliability and validity of the Mini-Mental State in a British community survey. J Psychiatr Res (1989) 1.51

Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry (1986) 1.51

Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn (1982) 1.38

An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol (1988) 1.33

Frequency of dementia in Parkinson disease. Arch Neurol (1996) 1.30

The neuropsychology of Parkinson's disease. Brain Cogn (1995) 1.25

Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol (1990) 1.20

Cognitive impairments and depression in Parkinson's disease: a follow up study. J Neurol Neurosurg Psychiatry (1990) 1.19

Parkinson's disease and dementia. Lancet (1985) 1.06

Dementia and cognitive impairment in Parkinson's disease. J Neurol Neurosurg Psychiatry (1988) 1.02

Depression and cognitive impairment in Parkinson's disease. Brain (1989) 1.01

Cognitive slowing in Parkinson's disease fails to respond to levodopa treatment: the 15-objects test. Neurology (1989) 1.01

Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol (1995) 1.00

Coexisting dementia and depression in Parkinson's disease. Arch Neurol (1989) 0.97

Dementia and Parkinson's disease. Br J Psychiatry (1989) 0.95

A case-control study of smoking habits, dementia, and other illnesses in idiopathic Parkinson's disease. Neurology (1987) 0.95

Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology (1995) 0.94

Disturbed frontal regulation of attention in Parkinson's disease. Brain (1993) 0.93

The influence of depression on memory. Acta Psychiatr Scand (1977) 0.93

Striatal control of locomotion, intentional actions and of integrating and perceptive activity. J Neurol Sci (1978) 0.92

Clinical features predicting dementia in idiopathic Parkinson's disease: a follow-up study. Neurology (1990) 0.92

[Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation]. Rev Neurol (Paris) (1985) 0.90

A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry (1992) 0.89

Depression in Parkinson's disease. Am J Psychiatry (1994) 0.89

Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment. Brain (1993) 0.88

Dementia prevalence in Parkinson's disease. Lancet (1985) 0.87

Cognitive impairments in Parkinson's disease. Adv Neurol (1987) 0.87

Risk factors for dementia in Parkinson's disease. Adv Neurol (1990) 0.82

Different cognitive profiles on standard behavioral tests in Parkinson's disease and Alzheimer's disease. J Clin Exp Neuropsychol (1989) 0.82

Cognitive impairment and dementia in Parkinson's disease: a controlled study. Psychol Med (1991) 0.81

[Long-term study of 416 cases of Parkinson disease. Prognostic factors and therapeutic implications]. Rev Neurol (Paris) (1986) 0.80

Late cognitive changes in Parkinson's disease with an emphasis on dementia. Adv Neurol (1995) 0.79

[Cognitive deficits in Parkinson's disease]. Rev Neurol (Paris) (1991) 0.78

Alzheimer pathology in Parkinson's disease. Neurology (1989) 0.78

A pilot study of risk factors for dementia in Parkinson's disease. Mov Disord (1990) 0.78

Subcortical dementia. BMJ (1993) 0.77

Cognitive impairments and depression in Parkinson's disease. J Neurol Neurosurg Psychiatry (1991) 0.77

[Alzheimer's disease and Parkinson's disease: neuropsychological differentiation]. Rev Neurol (Paris) (1989) 0.77

Understanding the dynamics of Ebola epidemics. Epidemiol Infect (2006) 5.81

Influenza vaccine: the challenge of antigenic drift. Vaccine (2007) 4.23

Causality assessment of adverse reactions to drugs--II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol (1993) 2.89

Surveillance of influenza-like illness in France. The example of the 1995/1996 epidemic. J Epidemiol Community Health (1998) 2.86

A method for assessing the global spread of HIV-1 infection based on air travel. Math Popul Stud (1992) 2.14

Sentiweb: French communicable disease surveillance on the World Wide Web. BMJ (1996) 1.94

A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health (1991) 1.90

Genetic heterogeneity in familial idiopathic basal ganglia calcification (Fahr disease). Neurology (2004) 1.87

Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest (2000) 1.86

Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's disease. J Neurol Neurosurg Psychiatry (2008) 1.83

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations. Ann Neurol (1980) 1.78

Familial idiopathic cerebral calcifications. J Neurol Neurosurg Psychiatry (1977) 1.75

Normal rates of forgetting of verbal and non-verbal material in Alzheimer's disease. Cortex (1987) 1.68

Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol (1998) 1.66

Risk factors for winter outbreak of acute diarrhoea in France: case-control study. BMJ (1998) 1.65

Dual infections by influenza A/H3N2 and B viruses and by influenza A/H3N2 and A/H1N1 viruses during winter 2007, Corsica Island, France. J Clin Virol (2008) 1.62

Clinical evaluation of circulating blood volume in critically ill patients--contribution of a clinical scoring system. Br J Anaesth (2001) 1.60

Forecasting disease risk for increased epidemic preparedness in public health. Adv Parasitol (2000) 1.54

Severe impairment battery. A neuropsychological test for severely demented patients. Arch Neurol (1994) 1.51

EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology (1997) 1.48

Efficacy of intraoperative dexmedetomidine compared with placebo for surgery in adults: a meta-analysis of published studies. Minerva Anestesiol (2015) 1.48

A mathematical model for evaluating the impact of vaccination schedules: application to Neisseria meningitidis. Epidemiol Infect (2003) 1.46

Thrombocytopenia in a surgical ICU. Chest (1999) 1.45

Psychiatric medication and abnormal behavior as predictors of progression in probable Alzheimer disease. Arch Neurol (1999) 1.45

Investigating transmission in a two-wave epidemic of Chikungunya fever, Réunion Island. Vector Borne Zoonotic Dis (2008) 1.43

Pyramidal tract signs and Parkinson's disease. Lancet (1992) 1.41

Visuospatial impairment in Parkinson's disease. Role of perceptual and motor factors. Arch Neurol (1984) 1.41

[Difficulties in differential diagnosis of long-term Creutzfeldt- Jakob disease]. Neurologia (1995) 1.39

p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck. J Clin Oncol (2000) 1.39

Postoperative decrease in plasma sodium concentration after infusion of hypotonic intravenous solutions in neonatal surgery. Br J Anaesth (2013) 1.39

[Specialized memory consultation. Value and evaluation after 2 years of functioning]. Presse Med (1993) 1.38

The geographical spread of influenza. Proc Biol Sci (1998) 1.38

The alien hand syndrome. Clinical and postmortem findings. Arch Neurol (1989) 1.35

Sentinel monitoring of general community health during the 1998 World Football Cup. Rev Epidemiol Sante Publique (2001) 1.34

The primate motor thalamus. Brain Res Brain Res Rev (1996) 1.33

Enhancing global capacity in the surveillance, prevention, and control of chronic diseases: seven themes to consider and build upon. J Epidemiol Community Health (2008) 1.31

[Prevalence and management of heart failure in France: national study among general practitioners of the Sentinelles network]. Rev Med Interne (2005) 1.28

Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther (2003) 1.24

Extrapyramidal signs in patients with probable Alzheimer disease. Arch Neurol (1997) 1.20

Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol (1998) 1.20

[Could treatments with beta-blockers be associated with a reduction in cancer risk?]. Rev Epidemiol Sante Publique (2004) 1.19

The natural history of Alzheimer's disease. Description of study cohort and accuracy of diagnosis. Arch Neurol (1994) 1.17

Amygdala atrophy in Alzheimer's disease. An in vivo magnetic resonance imaging study. Arch Neurol (1993) 1.15

Corticosteroid-induced clinical adverse events: frequency, risk factors and patient's opinion. Br J Dermatol (2007) 1.14

Role of videoendoscopy in assessment of pharyngeal function in oropharyngeal dysphagia: comparison with videofluoroscopy and manometry. Laryngoscope (1998) 1.14

Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene (2006) 1.14

Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms. Am J Respir Cell Mol Biol (1999) 1.13

Neuropsychological function in Alzheimer's disease. Pattern of impairment and rates of progression. Arch Neurol (1988) 1.09

Axial motor disturbances after hypoxic lesions of the globus pallidus. Mov Disord (1993) 1.08

Simple reaction time: evidence for focal impairment from lesions of the right hemisphere. Brain (1975) 1.08

Maurice Ravel and right-hemisphere musical creativity: influence of disease on his last musical works? Eur J Neurol (2002) 1.04

Fetal hemoglobin and F-cell responses to long-term hydroxyurea treatment in young sickle cell patients. The French Study Group on Sickle Cell Disease. Blood (1998) 1.04

MRI description of cerebral atrophy in mouse lemur primates. Neurobiol Aging (2000) 1.04

AIDS-related Pneumocystis carinii pneumonia in the era of adjunctive steroids: implication of BAL neutrophilia. Am J Respir Crit Care Med (1999) 1.03

Spino-pontine degeneration. Eur Neurol (1969) 1.03

Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients. J Immunol (2001) 1.03

Computerized EEG spectral analysis in elderly normal, demented and depressed subjects. Electroencephalogr Clin Neurophysiol (1986) 1.03

HIV and travel, no rationale for restrictions. Lancet (1990) 1.02

Epidemiology of chickenpox in France (1991-1995). J Epidemiol Community Health (1998) 1.01

Anosognosia, intrusions and 'frontal' functions in Alzheimer's disease and depression. Neuropsychologia (1995) 1.01

Familial palilalia. Neurology (1973) 1.00

[Herpes zoster: incidence study among "sentinel" general practitioners]. Ann Dermatol Venereol (2001) 1.00

Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol (1995) 1.00

Latent sensory aphasia in hemisphere-damaged patients: an experimental study with the Token Test. Brain (1966) 0.99

Cognitive deficits and clinical diagnosis of Alzheimer's disease. Neurology (1987) 0.98

Discrimination of facial identity and of emotions in Alzheimer's disease. J Neurol Sci (1998) 0.97

Serological study of the 2009 pandemic due to influenza A H1N1 in the metropolitan French population. Clin Microbiol Infect (2011) 0.97

Corticosteroid-induced lipodystrophy is associated with features of the metabolic syndrome. Rheumatology (Oxford) (2007) 0.95

Modelling responses to a smallpox epidemic taking into account uncertainty. Epidemiol Infect (2004) 0.95

Association of the apolipoprotein E epsilon4 allele with late-onset depression. Neuroepidemiology (2001) 0.95

Dementia in Parkinson's disease: a population-based study in ambulatory and institutionalized individuals. Neurology (1995) 0.94

Topographic distribution of the axonal endings from the sensorimotor and associative striatum in the macaque pallidum and substantia nigra. Exp Brain Res (1994) 0.94

AIDS-related alveolar hemorrhage: a prospective study of 273 BAL procedures. Chest (2001) 0.94

Low-frequency repetitive TMS of premotor cortex can reduce painful axial spasms in generalized secondary dystonia: a pilot study of three patients. Neurophysiol Clin (2004) 0.94

Cerebral T2-weighted signal decrease during aging in the mouse lemur primate reflects iron accumulation. Neurobiol Aging (1998) 0.94

Lyme disease in France: a primary care-based prospective study. Epidemiol Infect (2005) 0.94

Status of electronic reporting of notifiable conditions in the United States and Europe. Telemed J (1996) 0.94

Learning deficit in Parkinson's disease. Comparison with Alzheimer's disease and normal aging. Arch Neurol (1987) 0.94

Computed tomography--but not magnetic resonance imaging--identified periventricular white-matter lesions predict symptomatic cerebrovascular disease in probable Alzheimer's disease. Arch Neurol (1995) 0.94

Six years of sentinel surveillance of hepatitis B in general practice in France. Eur J Epidemiol (1998) 0.93

Increased plasma neurotensin concentrations in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 0.93

Thalamic and subcortical gliosis with dementia. Arch Neurol (1987) 0.92

Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's disease. Arch Neurol (1988) 0.92

Family study of platelet membrane fluidity in Alzheimer's disease. Science (1987) 0.92

Risk of dementia in relatives of patients with Alzheimer's disease. Neurology (1988) 0.91

Neuropsychiatric correlates of cerebral white-matter radiolucencies in probable Alzheimer's disease. Arch Neurol (1992) 0.90

Palilalia. Br J Disord Commun (1975) 0.89

A space-time criterion for early detection of epidemics of influenza-like-illness. Eur J Epidemiol (1998) 0.89

Sentiweb remains efficient tool for nationwide surveillance of disease. BMJ (1997) 0.89

[Multi-infarct disorder presenting as corticobasal degeneration (DCB): vascular pseudo-corticobasal degeneration?]. Rev Neurol (Paris) (2007) 0.88

[Prognostic factors in advanced pancreatic cancer. Multivariate analysis of predictive survival score. University Surgery Association]. Ann Chir (2000) 0.88

Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest (1996) 0.88

Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study. Gut (2003) 0.87

[Prophylactic prescription of low-molecular-weight heparin in the non-surgical setting: impact of recommendations]. Presse Med (2001) 0.87

Acalculia: historical development and current significance. Brain Cogn (1983) 0.87

AIDS-associated progressive multifocal leukoencephalopathy revealed by new-onset seizures. Am J Med (1995) 0.87

Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med (1993) 0.87

Comparison of the statistical efficiency of case-crossover and case-control designs: application to severe cutaneous adverse reactions. J Clin Epidemiol (2001) 0.87

A seroepidemiological study of pandemic A/H1N1(2009) influenza in a rural population of Mali. Clin Microbiol Infect (2012) 0.86